Innate immune responses to mycobacteria and the downregulation of atopic responses

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 5, 2003, Pages 337-342

  Rook, Graham A W ^a   Martinelli, Roberta ^a   Brunet, Laura Rosa ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Allergic disorders; Gene polymorphisms; Immunoregulation by mycobacteria; Innate immunity; Regulatory T cells

Indexed keywords

CD14 ANTIGEN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; TOLL LIKE RECEPTOR 2;

AGRICULTURAL WORKER; ALLERGIC DISEASE; ALLERGY; ANTIGEN RECOGNITION; ASTHMA; ATOPY; CELLULAR IMMUNITY; CLINICAL FEATURE; CONGENIC STRAIN; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE PREDISPOSITION; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; HYGIENE; IMMUNE RESPONSE; IMMUNOREGULATION; LEPROSY; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD14; ASTHMA; CATION TRANSPORT PROTEINS; DOWN-REGULATION; ENVIRONMENTAL EXPOSURE; HUMANS; HYPERSENSITIVITY; IMMUNITY, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; MYCOBACTERIUM; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS;

EID: 0141885424     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200310000-00003     Document Type: Review

References (72)

1. van den Biggelaar AH, van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723-1727.
2. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 2001; 358:1129-1133.
3. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-877. A compelling analysis of the correlations between the exposure to endotoxin and the incidence of atopy and of allergic symptoms.
4. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-920. A very comprehensive review of the hygiene hypothesis, and of the possible roles of infections and other microorganisms. A very balanced analysis of the various different views, which takes into account the evidence for simultaneous increases in several groups of disease.
5. Umetsu DT, McIntire JJ, Akbari O, et al. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002; 3:715-720. An excellent review of the evidence indicating that the 'hygiene hypothesis' is best explained by changes in the efficacy of regulatory T cells.
6. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73.
7. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27:18-20.
8. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-1061. A gem of a paper. Everyone should read it. An example of clarity and insight. It provides proof of the fundamental role of Foxp3 in the development and function of Tregs.
9. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol 2003; 4:330-336. Another striking paper, backing up the findings in Ref. [8••], showing that Foxp3 is a marker of Tregs.
10. Belkaid Y, Piccirillo CA, Mendez S, et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:502-507. An extremely elegant demonstration of the role of Tregs in the course of infection. It shows that Tregs block sterile immunity, but by allowing a few parasites to persist and release low levels of antigen, promote concomitant immunity.
11. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002; 8:71-80. This study shows that a lactobacillus, unlike commensal gut flora, may fail to provoke significant colitis in colitis-susceptible mice, and can protect from subsequent exposure to colitis-inducing commensal flora.
12. Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003; 3:15-20. An excellent review of the role of intestinal flora, and includes a careful assessment of the work on lactobacilli, which has not received enough attention.
13. Rook GAW, Stanford JL. Give us this day our daily germs. Immunol Today 1998; 19:113-116.
14. Zuany-Amorim C, Sawicka E, Manlius C, et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8:625-629. A detailed and thorough series of experiments that prove the ability of a saprophytic environmental mycobacterium to work in an allergy model by activating regulatory T cells.
15. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296:490-494. An excellent broad discussion of the role of helminths in the low incidence of allergic disorders in developing countries. One of the papers that has helped to terminate the earlier view that the increase in allergies in the west is caused by an imbalance of T helper type 1 and type 2 cells.
16. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-1079.
17. Arkwright PD, David TJ, Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001; 107:531-534.
18. Camporota L, Corkhill A, Long H, et al. The effects of Mycobacterium vaccae on allergen-induced airway responses in atopic asthma. Eur Respir J 2003; 21:287-293.
19. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277:48122-48129. A fascinating study of the effects of schistosome extracts on the function of DCs, and evidence for molecular structures that cause the DC to drive T cells that make IL-10.
20. Vercelli D. The functional genomics of CD14 and its role in IgE responses: an integrated view. J Allergy Clin Immunol 2002; 109:14-21.
21. Pfeiffer A, Bottcher A, Orso E, et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur J Immunol 2001; 31:3153-3164.
22. Triantafilou M, Miyake K, Golenbock DT; Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002; 115:2603-2611.
23. Triantafilou M, Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002; 23:301-304. A useful review of the complexity of signalling via TLRS.
24. Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411. An important paper (commentary by Sakaguchi in the same journal) pointing out that TLRs on T cells are important in addition to the more usually studied TLRs on DCs. Tregs differ from Teffs in their relative expression levels of different TLRs.
25. O'Neill LA. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol 2002; 23:296-300. A useful review of signalling via TLR4 and TLR2.
26. Zarember KA, Godowski PJ. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002; 168:554-561.
27. Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-4537. Helpful data on the differential expression of TLRs in the various subsets of peripheral blood cells studied in most laboratories.
28. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002; 4:937-944. An essential review of the known observations on the roles of TLRs in immunity to mycobacteria, and on the components of mycobacteria that signal via TLRs.
29. Seya T, Matsumoto M, Tsuji S, et al. Structural-functional relationship of pathogen-associated molecular patterns: lessons from BCG cell wall skeleton and mycoplasma lipoprotein M161Ag. Microbes Infect 2002; 4:955-961.
30. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10-14. An elegant demonstration of the differing roles of different TLR heterodimers in the recognition of diacylated and triacylated microbial products.
31. Morr M, Takeuchi O, Akira S, et al. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 2002; 32:3337-3347.
32. Kang TJ, Lee SB, Chae GT. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002; 20:56-62. This group of workers first detected the relationship between TLR2 polymorphisms and lepromatous leprosy.
33. Bochud PY, Hawn TR, Aderem A. Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 2003; 170:3451-3454. This study provides a molecular explanation for the observations of Kang et al. [32•]. The TLR2 polymorphism associated with lepromatous leprosy entirely fails to signal.
34. Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169:3480-3484. This study shows that under the appropriate conditions, signalling via TLR 2 and TLR4 is relevant to immunity to M. tuberculosis.
35. Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169:3155-3162.
36. Stenger S, Modlin RL. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 2002; 14:452-457.
37. Ronaghy A, Prakken BJ, Takabayashi K, et al. Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol 2002; 168:51-56.
38. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360:465-466. This study describes the remarkable finding that exposure to the farming environment, which protects against allergic manifestations, also causes changes in expression levels of mRNA encoding TLR2 and CD14.
39. Raby BA, Klimecki WT, Laprise C, et al. Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166:1449-1456.
40. Dabbagh K, Dahl ME, Stepick-Biek P, Lewis DB. Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J Immunol 2002; 168:4524-4530.
41. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001; 276:37692-37699.
42. Oppmann B, Lesley R, Blom B, etal. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
43. Van der Kleij D, Van Remoortere A, Schuitemaker JH, et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1-4(Fuc alpha 1-2Fuc alpha 1-3)GIcNAc. J Infect Dis 2002; 185:531-539.
44. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277:15028-15034.
45. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 2002; 168:1435-1440.
46. van Eden W, Koets A, van Kooten P, et al. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 2003; 21:897-901. HSPs are highly conserved, and both microbial and human HSPs can trigger via the innate immune system, and can drive Treg formation.
47. Baldini M, Lohman IC, Halonen M, et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-983.
48. Sengler C, Haider A, Sommerfeld C, et al. Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy 2003; 33:166-169.
49. Jones CA, Holloway JA, Popplewell EJ, et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 2002; 109:858-866. Fascinating circumstantial evidence that CD14 is important in the regulation of the immune mechanisms that underlie allergic disorders. The study also implies that these effects may occur early in life.
50. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 2002; 70:6688-6696.
51. Soborg C, Andersen AB, Madsen HO, et al. Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J Infect Dis 2002; 186:517-521.
52. Meisner SJ, Mucklow S, Warner G, et al. Association of NRAMP1 polymorphism with leprosy type but not susceptibility to leprosy per se in west Africans. Am J Trop Med Hyg 2001; 65:733-735.
53. Ma X, Dou S, Wright JA, et al. 5′ Dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis 2002; 6:818-823.
54. Liaw YS, Tsai-Wu JJ, Wu CH, et al. Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int J Tuberc Lung Dis 2002; 6:454-460.
55. Awomoyi AA, Marchant A, Howson JM, et al. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002; 186:1808-1814. This study links Nramp1 (Slc11a1), IL-10 and tuberculosis.
56. Aim JS, Sanjeevi CB, Miller EN, et al. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S 1471. Genes Immun 2002; 3:71-77. This study suggests that Nrampl (Slc11a1) might be involved in atopy, but in a way that depends upon exposure to BCG. This concept, although still tentative, begins to look exciting in the light of Refs [55•] and [60].
57. Kojima Y, Kinouchi Y, Takahashi S, et al. Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens 2001; 58:379-384.
58. Kotze MJ, de Villiers JN, Rooney RN, et al. Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cell Mol Dis 2001; 27:44-53.
59. Rodriguez MR, Gonzalez-Escribano MF, Aguilar F, et al. Association of NRAMP1 promoter gene polymorphism with the susceptibility and radiological severity of rheumatoid arthritis. Tissue Antigens 2002; 59:311-315.
60. Smit JJ, Van Loveren H, Hoekstra MO, et al. Influence of the macrophage bacterial resistance gene Nramp1 (Slc11a1) on the induction of allergic asthma in the mouse. FASEB J 2003; 17:958-960.
61. Dutronc Y, Porcelli SA. The CD1 family and T cell recognition of lipid antigens. Tissue Antigens 2002; 60:337-353. An essential review of the CD1-restricted T cells, and what they recognize. Numerous mycobacterial components appear in the list!
62. Jahnsen FL, Moloney ED, Hogan T, et al. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001; 56:823-826.
63. Vincent MS, Leslie DS, Gumperz JE, et al. CD1-dependent dendritic cell instruction. Nat Immunol 2002; 3:1163-1168. A paper showing that CD1-restricted T cells recognizing self lipid components presented by DCs, play a role in DC maturation. This is fascinating because mycobacteria contain ligands for all types of CD1-restricted T cells, and would therefore modulate this pathway of DC 'instruction'.
64. Tomita K, Lim S, Hanazawa T, et al. Attenuated production of intracellular IL-10 and IL-12 in monocytes from patients with severe asthma. Clin Immunol 2002; 102:258-266. This study confirms earlier weaker studies that indicated low production of IL-10 by cells from asthmatic individuals. In view of the role of IL-10 in Treg function, this is an important point. However, it is a pity that the authors used only a TLR4 trigger. Such work should be repeated with a TLR2 ligand.
65. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998; 352:113.
66. Arkwright PD, Chase JM, Babbage S, et al. Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol 2001; 108:281-284.
67. Lee SY, Lee YH, Shin C, et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002; 122:171-176. CTLA-4 is fundamental to the function of Tregs, so the association of asthma symptoms with polymorphisms of this gene is clearly important.
68. Wjst M, Kruse S, Illig T, Deichmann K. Asthma and IL-4 receptor alpha gene variants. Eur J Immunogenet 2002; 29:263-268.
69. Tanaka K, Roberts MH, Yamamoto N, et al. Genetic variants of the receptors for thromboxane A2 and IL-4 in atopic dermatitis. Biochem Biophys Res Commun 2002; 292:776-780.
70. Risma KA, Wang N, Andrews RP, et al. V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function. J Immunol 2002; 169:1604-1610. This study shows that a polymorphism leading to enhanced IL-4 receptor function is associated with asthma. It would be nice to know what the same polymorphism does to susceptibility to tuberculosis.
71. Callard RE, Hamvas R, Chatterton C, et al. An interaction between the IL-4Ralpha gene and infection is associated with atopic eczema in young children. Clin Exp Allergy 2002; 32:990-993.
72. Seah GT, Scott GM, Rook GA. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis 2000; 181:385-389.